2020 NIAID Omnibus Broad Agency Announcement

Award Notice Posted

Solicitation number
HHS-NIH-NIAID-BAA2020-1
Agency
Awarded
to Spero Therapeutics, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N93021C00022 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases awarded Spero Therapeutics, Inc. a cost-reimbursement contract valued at $2,337,492 to provide unspecified goods or services in support of the agency's research efforts under the 2020 NIAID Omnibus Broad Agency Announcement. The contract carries number 75N93021C00022 and has a period of performance through May 12, 2021. The award was made on a cost-reimbursement basis given that costs could not be adequately defined at the time of award under full and open competition.

Notice text

This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.

Awarded contract 75N93021C00022 to SPERO THERAPEUTICS, INC. for 23373492.00 on 2021-05-12.

Notice history

Notice Type Posted
This notice Latest Award Notice
2020 NIAID Omnibus Broad Agency Announcement Award Notice
2020 NIAID Omnibus Broad Agency Announcement Award Notice
2020 NIAID Omnibus Broad Agency Announcement Award Notice
2020 NIAID Omnibus Broad Agency Announcement Latest solicitation Solicitation
2020 NIAID Omnibus Broad Agency Announcement Original Pre-Solicitation

6 of 11 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors